Compare Jubilant Agri with Similar Stocks
Stock DNA
Specialty Chemicals
INR 3,242 Cr (Small Cap)
36.00
53
0.00%
0.07
21.42%
7.78
Total Returns (Price + Dividend) 
Jubilant Agri for the last several years.
Risk Adjusted Returns v/s 
Returns Beta
News
Is Jubilant Agri overvalued or undervalued?
As of 6 November 2025, the valuation grade for Jubilant Agri has moved from expensive to attractive, indicating a shift in its perceived value. The company is currently assessed as undervalued. Key ratios include a PE ratio of 44.26, an EV to EBITDA of 28.01, and a Price to Book Value of 0.95, which suggest that the stock may be trading at a discount compared to its intrinsic value. In comparison to its peers, Jubilant Agri's PE ratio is notably lower than that of Hindustan Unilever at 54.11 and Nestle India at 81.85, both of which are categorized as very expensive. This positions Jubilant Agri favorably within the specialty chemicals sector. Additionally, the company's recent stock performance has outpaced the Sensex, with a 1-week return of 4.67% compared to the Sensex's decline of 1.30%, reinforcing the attractiveness of its current valuation....
Read full news articleHow has been the historical performance of Jubilant Agri?
Answer: The historical performance of Jubilant Agri shows significant growth in key financial metrics from March 2024 to March 2025. Breakdown: Jubilant Agri's net sales increased from 1,253.26 Cr in March 2024 to 1,561.03 Cr in March 2025, reflecting a strong growth trend. Total operating income followed suit, rising to 1,561.03 Cr from 1,253.26 Cr. However, total expenditure also rose, from 1,146.05 Cr to 1,414.82 Cr, driven by higher raw material costs and employee expenses. Operating profit (PBDIT) improved to 147.46 Cr from 108.63 Cr, while profit before tax surged to 117.90 Cr from 40.47 Cr, leading to a profit after tax of 88.30 Cr compared to 30.68 Cr the previous year. The earnings per share (EPS) saw a notable increase from 19.72 to 58.23. On the balance sheet, shareholder's funds rose to 325.51 Cr from 235.27 Cr, and total liabilities decreased slightly from 742.42 Cr to 734.99 Cr. Cash flow fro...
Read full news article Announcements 
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
06-Jan-2026 | Source : BSEPlease find the attached intimation Letter regarding allotment of Shares against exercise of ESOP Options
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
05-Jan-2026 | Source : BSEPlease find attached the certificate.
Letters Dispatched To Shareholders Whose Shares Are Lying In IEPF Account / Demat Suspense Accounts
02-Jan-2026 | Source : BSEPlease find attached copies of letters dispatched to Shareholders of the Company
Corporate Actions 
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Sep 2025
Shareholding Compare (%holding) 
Promoters
None
Held by 1 Schemes (0.0%)
Held by 8 FIIs (0.25%)
Hsb Trustee Company Pvt Ltd (35.3%)
Chetan Jayantilal Shah (2.44%)
18.32%
Quarterly Results Snapshot (Standalone) - Sep'25 - QoQ
QoQ Growth in quarter ended Sep 2025 is 18.55% vs 11.39% in Jun 2025
QoQ Growth in quarter ended Sep 2025 is 10.67% vs 187.12% in Jun 2025
Half Yearly Results Snapshot (Standalone) - Sep'25
Not Applicable: The company has declared_date for only one period
Not Applicable: The company has declared_date for only one period
Nine Monthly Results Snapshot (Standalone) - Dec'24
Not Applicable: The company has declared_date for only one period
Not Applicable: The company has declared_date for only one period
Annual Results Snapshot (Standalone) - Mar'25
Not Applicable: The company has declared_date for only one period
Not Applicable: The company has declared_date for only one period






